We are live on ! Find out more
PRQR icon

ProQR Therapeutics
PRQR

23 hedge funds and large institutions have $43.6M invested in ProQR Therapeutics in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

38.07% more ownership

Funds ownership: 0% → 38.07% (+38%)

8% less funds holding

Funds holding: 25 → 23 (-2)

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

25% less capital invested

Capital invested by funds: $58M → $43.6M (-$14.4M)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
23
Holders Change
-2
Holders Change %
-8%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$5.16M
2
SFM
Sphera Funds Management
Israel
+$1.03M
3
Morgan Stanley
Morgan Stanley
New York
+$93.8K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$33.1K
5
Millennium Management
Millennium Management
New York
+$13.9K

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$3.34M
2
HCMT
Highland Capital Management (Texas)
Texas
-$1.71M
3
Asset Management One
Asset Management One
Japan
-$255K
4
Jennison Associates
Jennison Associates
New York
-$164K
5
SM
Sabby Management
Florida
-$97.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jennison Associates
1
Jennison Associates
New York
$12.7M -$164K -31,920 -1%
O
2
OrbiMed
New York
$11.3M – – –
RG
3
Redmile Group
California
$7.73M +$5.16M +1,002,311 +174%
ClearBridge Investments
4
ClearBridge Investments
New York
$2.45M +$1.44K +279 +0.1%
JHIU
5
Janus Henderson Investors US
Colorado
$1.93M -$42.4K -8,236 -2%
Franklin Resources
6
Franklin Resources
California
$1.52M – – –
Fidelity Investments
7
Fidelity Investments
Massachusetts
$1.17M – – –
BBA
8
Baker Bros. Advisors
New York
$1.04M -$3.34M -647,766 -75%
AGA
9
Altrinsic Global Advisors
Connecticut
$1.03M – – –
SFM
10
Sphera Funds Management
Israel
$980K +$1.03M +200,000 New
Millennium Management
11
Millennium Management
New York
$745K +$13.9K +2,706 +2%
Principal Financial Group
12
Principal Financial Group
Iowa
$375K – – –
Morgan Stanley
13
Morgan Stanley
New York
$255K +$93.8K +18,211 +54%
SM
14
Sabby Management
Florida
$196K -$97.4K -18,910 -32%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$55K +$1.22K +236 +2%
Wells Fargo
16
Wells Fargo
California
$53K -$927 -180 -2%
Acadian Asset Management
17
Acadian Asset Management
Massachusetts
$31K +$33.1K +6,422 New
JP Morgan Chase
18
JP Morgan Chase
New York
$17K -$43.7K -8,485 -70%
Creative Planning
19
Creative Planning
Kansas
$9K +$7.73K +1,500 +375%
UBS Group
20
UBS Group
Switzerland
$6K +$6.63K +1,286 New
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
$3K – – –
CCM
22
Cribstone Capital Management
Maine
$1K -$3.68K -714 -71%
HCMT
23
Highland Capital Management (Texas)
Texas
– -$1.71M -256,596 Closed
Asset Management One
24
Asset Management One
Japan
– -$255K -37,786 Closed
M&T Bank
25
M&T Bank
New York
– -$83K -12,416 Closed
1
2

PRQR Hedge Fund Activity: Q4 2016 in Review

23 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q4 2016, worth a combined $43.6M — down 25% from $58M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of PRQR and 4 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 6 added.

The largest buyer was Redmile Group, adding an estimated $5.16M. The largest seller was Baker Bros. Advisors, cutting an estimated $3.34M.

  • 23 institutional investors held ProQR Therapeutics (PRQR) as of Q4 2016, down from 25 in Q3 2016.
  • Funds reported $43.6M of ProQR Therapeutics stock for Q4 2016, down 25% quarter-over-quarter.
  • 4 funds opened new ProQR Therapeutics positions in Q4 2016 and 6 closed out, a net change of -2 holders.
  • The largest ProQR Therapeutics buyer in Q4 2016 was Redmile Group, an estimated $5.16M added.
  • The largest ProQR Therapeutics seller in Q4 2016 was Baker Bros. Advisors, an estimated $3.34M sold.

Based on aggregated 13F filings for Q4 2016.